Femke Lutgendorff
Linköping University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Femke Lutgendorff.
Inflammatory Bowel Diseases | 2010
Kimberley Lewis; Femke Lutgendorff; Van Phan; Johan D. Söderholm; Philip M. Sherman; Derek M. McKay
Background: The gut microflora in some patients with Crohns disease can be reduced in numbers of butyrate‐producing bacteria and this could result in metabolic stress in the colonocytes. Thus, we hypothesized that the short‐chain fatty acid, butyrate, is important in the maintenance and regulation of the barrier function of the colonic epithelium. Methods: Confluent monolayers of the human colon‐derived T84 or HT‐29 epithelial cell lines were exposed to dinitrophenol (DNP (0.1 mM), uncouples oxidative phosphorylation) + Escherichia coli (strain HB101, 106 cfu) ± butyrate (3–50 mM). Transepithelial resistance (TER), and bacterial internalization and translocation were assessed over a 24‐hour period. Epithelial ultrastructure was assessed by transmission electron microscopy. Results: Epithelia under metabolic stress display decreased TER and increased numbers of pseudopodia that is consistent with increased internalization and translocation of the E. coli. Butyrate (but not acetate) significantly reduced the bacterial translocation across DNP‐treated epithelia but did not ameliorate the drop in TER in the DNP+E. coli exposed monolayers. Inhibition of bacterial transcytosis across metabolically stressed epithelia was associated with reduced I‐&kgr;B phosphorylation and hence NF‐&kgr;B activation. Conclusions: Reduced butyrate‐producing bacteria could result in increased epithelial permeability particularly in the context of concomitant exposure to another stimulus that reduces mitochondria function. We speculate that prebiotics, the substrate for butyrate synthesis, is a valuable prophylaxis in the regulation of epithelial permeability and could be of benefit in preventing relapses in IBD. (Inflamm Bowel Dis 2010)
PLOS ONE | 2009
Femke Lutgendorff; Rian M. Nijmeijer; Per Sandström; Lena M. Trulsson; Karl-Eric Magnusson; Harro M. Timmerman; L. Paul van Minnen; Ger T. Rijkers; Hein G. Gooszen; L. M. A. Akkermans; Johan D. Söderholm
Background During acute pancreatitis (AP), oxidative stress contributes to intestinal barrier failure. We studied actions of multispecies probiotics on barrier dysfunction and oxidative stress in experimental AP. Methodology/Principal Findings Fifty-three male Spraque-Dawley rats were randomly allocated into five groups: 1) controls, non-operated, 2) sham-operated, 3) AP, 4) AP and probiotics and 5) AP and placebo. AP was induced by intraductal glycodeoxycholate infusion and intravenous cerulein (6 h). Daily probiotics or placebo were administered intragastrically, starting five days prior to AP. After cerulein infusion, ileal mucosa was collected for measurements of E. coli K12 and 51Cr-EDTA passage in Ussing chambers. Tight junction proteins were investigated by confocal immunofluorescence imaging. Ileal mucosal apoptosis, lipid peroxidation, and glutathione levels were determined and glutamate-cysteine-ligase activity and expression were quantified. AP-induced barrier dysfunction was characterized by epithelial cell apoptosis and alterations of tight junction proteins (i.e. disruption of occludin and claudin-1 and up-regulation of claudin-2) and correlated with lipid peroxidation (r>0.8). Probiotic pre-treatment diminished the AP-induced increase in E. coli passage (probiotics 57.4±33.5 vs. placebo 223.7±93.7 a.u.; P<0.001), 51Cr-EDTA flux (16.7±10.1 vs. 32.1±10.0 cm/s10−6; P<0.005), apoptosis, lipid peroxidation (0.42±0.13 vs. 1.62±0.53 pmol MDA/mg protein; P<0.001), and prevented tight junction protein disruption. AP-induced decline in glutathione was not only prevented (14.33±1.47 vs. 8.82±1.30 nmol/mg protein, P<0.001), but probiotics even increased mucosal glutathione compared with sham rats (14.33±1.47 vs. 10.70±1.74 nmol/mg protein, P<0.001). Glutamate-cysteine-ligase activity, which is rate-limiting in glutathione biosynthesis, was enhanced in probiotic pre-treated animals (probiotics 2.88±1.21 vs. placebo 1.94±0.55 nmol/min/mg protein; P<0.05) coinciding with an increase in mRNA expression of glutamate-cysteine-ligase catalytic (GCLc) and modifier (GCLm) subunits. Conclusions Probiotic pre-treatment diminished AP-induced intestinal barrier dysfunction and prevented oxidative stress via mechanisms mainly involving mucosal glutathione biosynthesis.
American Journal of Physiology-gastrointestinal and Liver Physiology | 2008
Femke Lutgendorff; Lena M. Trulsson; L. Paul van Minnen; Ger T. Rijkers; Harro M. Timmerman; Lennart Franzén; Hein G. Gooszen; L. M. A. Akkermans; Johan D. Söderholm; Per Sandström
Factors determining severity of acute pancreatitis (AP) are poorly understood. Oxidative stress causes acinar cell injury and contributes to the severity, whereas prophylactic probiotics ameliorate experimental pancreatitis. Our objective was to study how probiotics affect oxidative stress, inflammation, and acinar cell injury during the early phase of AP. Fifty-three male Sprague-Dawley rats were randomly allocated into groups: 1) control, 2) sham procedure, 3) AP with no treatment, 4) AP with probiotics, and 5) AP with placebo. AP was induced under general anesthesia by intraductal glycodeoxycholate infusion (15 mM) and intravenous cerulein (5 microg.kg(-1).h(-1), for 6 h). Daily probiotics or placebo were administered intragastrically, starting 5 days prior to AP. After cerulein infusion, pancreas samples were collected for analysis including lipid peroxidation, glutathione, glutamate-cysteine-ligase activity, histological grading of pancreatic injury, and NF-kappaB activation. The severity of pancreatic injury correlated to oxidative damage (r = 0.9) and was ameliorated by probiotics (1.5 vs. placebo 5.5; P = 0.014). AP-induced NF-kappaB activation was reduced by probiotics (0.20 vs. placebo 0.53 OD(450nm)/mg nuclear protein; P < 0.001). Probiotics attenuated AP-induced lipid peroxidation (0.25 vs. placebo 0.51 pmol malondialdehyde/mg protein; P < 0.001). Not only was AP-induced glutathione depletion prevented (8.81 vs. placebo 4.1 micromol/mg protein, P < 0.001), probiotic pretreatment even increased glutathione compared with sham rats (8.81 vs. sham 6.18 miccromol/mg protein, P < 0.001). Biosynthesis of glutathione (glutamate-cysteine-ligase activity) was enhanced in probiotic-pretreated animals. Probiotics enhanced the biosynthesis of glutathione, which may have reduced activation of inflammation and acinar cell injury and ameliorated experimental AP, via a reduction in oxidative stress.
PLOS ONE | 2013
Rian M. Nijmeijer; Hjalmar C. van Santvoort; Alexandra Zhernakova; Steffen Teller; Jonas A. Scheiber; Carolien G.F. de Kovel; Marc G. Besselink; Jeroen Visser; Femke Lutgendorff; Thomas L. Bollen; Marja A. Boermeester; Ger T. Rijkers; Frank Ulrich Weiss; Julia Mayerle; Markus M. Lerch; Hein G. Gooszen; L. M. A. Akkermans; Cisca Wijmenga
Introduction Impairment of the mucosal barrier plays an important role in the pathophysiology of acute pancreatitis. The myosin IXB (MYO9B) gene and the two tight-junction adaptor genes, PARD3 and MAGI2, have been linked to gastrointestinal permeability. Common variants of these genes are associated with celiac disease and inflammatory bowel disease, two other conditions in which intestinal permeability plays a role. We investigated genetic variation in MYO9B, PARD3 and MAGI2 for association with acute pancreatitis. Methods Five single nucleotide polymorphisms (SNPs) in MYO9B, two SNPs in PARD3, and three SNPs in MAGI2 were studied in a Dutch cohort of 387 patients with acute pancreatitis and over 800 controls, and in a German cohort of 235 patients and 250 controls. Results Association to MYO9B and PARD3 was observed in the Dutch cohort, but only one SNP in MYO9B and one in MAGI2 showed association in the German cohort (p < 0.05). Joint analysis of the combined cohorts showed that, after correcting for multiple testing, only two SNPs in MYO9B remained associated (rs7259292, p = 0.0031, odds ratio (OR) 1.94, 95% confidence interval (95% CI) 1.35-2.78; rs1545620, p = 0.0006, OR 1.33, 95% CI 1.16-1.53). SNP rs1545620 is a non-synonymous SNP previously suspected to impact on ulcerative colitis. None of the SNPs showed association to disease severity or etiology. Conclusion Variants in MYO9B may be involved in acute pancreatitis, but we found no evidence for involvement of PARD3 or MAGI2.
Current Molecular Medicine | 2008
Femke Lutgendorff; L. M. A. Akkermans; Johan D. Söderholm
Surgery | 2007
L. Paul van Minnen; Harro M. Timmerman; Femke Lutgendorff; Andre Verheem; Wil Harmsen; Sergey R. Konstantinov; Hauke Smidt; Maarten R. Visser; Ger T. Rijkers; Hein G. Gooszen; L. M. A. Akkermans
European Journal of Gastroenterology & Hepatology | 2006
Femke Lutgendorff; L. P. van Minnen; Harro M. Timmerman; H. G. Gooszen; Lma Akermans
Archive | 2013
Femke Lutgendorff; Anders Carlsson; Harro M. Timmerman; L. M. A. Akkermans; Johan D. Söderholm
Archive | 2013
Anders Carlsson; Femke Lutgendorff; L. M. A. Akkermans; Derek M. McKay; Johan D. Söderholm
Pancreas | 2007
Femke Lutgendorff; Lena M. Trulsson; L. P. van Minnen; Ger T. Rijkers; Harro M. Timmerman; Hein G. Gooszen; Johan D. Söderholm; L. M. A. Akkermans; Per Sandström